Tobira Therapeutics Inc  

(Public, NASDAQ:TBRA)   Watch this stock  
Find more results for Carol J. Cooper´┐Ż
13.14
-0.49 (-3.60%)
May 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 12.73 - 13.53
52 week 7.20 - 66.24
Open 13.52
Vol / Avg. 46,505.00/58,881.00
Mkt cap 144.24M
P/E     -
Div/yield     -
EPS -1.44
Shares 17.42M
Beta     -
Inst. own 0%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -153.93% -234.93%
Return on average equity - -
Employees 11 -
CDP Score - -

Address

701 Gateway Blvd Ste 300
SOUTH SAN FRANCISCO, CA 94080-7412
United States - Map
+1-650-7416625 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Tobira Therapeutics, Inc., formerly Regado BioSciences, Inc., is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics to treat liver disease, human immunodeficiency virus (HIV) fibrosis and inflammation. The Company's lead product candidate, cenicriviroc (CVC), is a dual CCR2/CCR5 antagonist with implications in fibrosis and HIV-1. The Company is evaluating CVC’s safety in multiple clinical studies, including the CENTAUR Study, an international, randomized Phase IIb study of CVC in patients with NASH and liver fibrosis. It studied CVC in Phase I and Phase II trials in approximately 600 subjects, including 115 infected with HIV-1 infected subjects on treatment for up to 48 weeks.

Officers and directors

Dennis G. Podlesak Chairman of the Board
Age: 57
Bio & Compensation  - Reuters
Laurent Fischer M.D. Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Christopher Peetz Chief Financial Officer
Age: 35
Bio & Compensation  - Reuters
Helen Jenkins Chief Operating Officer
Age: 50
Bio & Compensation  - Reuters
Christopher P. Rusconi Ph.D. Senior Vice President - Discovery/Preclinical Development , Chief Scientific Officer
Age: 46
Bio & Compensation  - Reuters
Nicholas J. Pelliccione Ph.D. Senior Vice President - Regulatory Affairs and Quality Assurance
Bio & Compensation  - Reuters
Christopher E. Courts CPA Vice President - Finance
Age: 44
Bio & Compensation  - Reuters
Eric Lefebvre M.D. Chief Medical Officer
Age: 50
Bio & Compensation  - Reuters
Carol L. Brosgart Director
Age: 63
Bio & Compensation  - Reuters
Jeffrey H. Cooper CPA Director
Age: 59
Bio & Compensation  - Reuters